Improvement of the therapeutic management of allergic patients in Europe – An expert think tank's position paper on allergen immunotherapy欧洲过敏患者治疗管理的改进——过敏原免疫疗法专家研讨会的立场文件World Allergy Organization JournalIF4.32025-09-120OAAI
The effect of mepolizumab dosage form on treatment outcomes in severe asthma美泊利单抗剂型对重症哮喘治疗效果的影响FRONTIERS IN MEDICINEIF32025-04-170OA
Systematic Approach Revealed SERPING1 Splicing-Affecting Variants to be Highly Represented in the Czech National HAE CohortJOURNAL OF CLINICAL IMMUNOLOGYIF5.72023-08-254OAAI
Registry-based analysis of Icatibant and C1-inhibitor use in treatment of laryngeal attacks of hereditary angioedemaCLINICAL AND EXPERIMENTAL ALLERGYIF5.22022-06-131PRE
Risk Factors for Severe COVID-19 and Hospital Admission in Patients With Inborn Errors of Immunity-Results From a Multicenter Nationwide StudyFRONTIERS IN IMMUNOLOGYIF5.92022-02-2825OAAI
The use of complementary and alternative medicine by adults with allergies: a Czech national representative surveyBMC COMPLEMENTARY MEDICINE AND THERAPIESIF3.42021-06-143OAAI
Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: Where do we stand today?INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGYIF2.62020-07-2017OAAI
Small, Prospective, Observational, Pilot Study in Patients with Severe Asthma after Discontinuation of Omalizumab TreatmentCLINICAL THERAPEUTICSIF3.62018-11-010PREAI
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During PregnancyJOURNAL OF CLINICAL IMMUNOLOGYIF5.72018-10-0219PREAI
Effect of omalizumab treatment on allergic comorbidities in patients with severe allergic asthma - real life experience from Czech Anti-IgE RegistryEUROPEAN RESPIRATORY JOURNALIF212017-12-061PRE
Pregnancy Outcome in Patients with Common Variable ImmunodeficiencyJOURNAL OF CLINICAL IMMUNOLOGYIF5.72015-08-1511PREAI
Validation of nitrite and nitrate measurements in exhaled breath condensateRESPIRATIONIF3.82006-03-2243PREAI
The comparison of influence of two different application forms of grass pollen immunotherapy - The changes on the level of cytokines IL-4 and IFN gamma after 24 months of immunotherapyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22006-02-010OA